Anne-Marie Langevin Selected Research

becatecarin (XL 119)

3/2008	A phase II trial of rebeccamycin analogue (NSC #655649) in children with solid tumors: a Children's Oncology Group study.
7/2003	Phase I trial of rebeccamycin analog (NSC #655649) in children with refractory solid tumors: a pediatric oncology group study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anne-Marie Langevin Research Topics

Disease

12	Neoplasms (Cancer) 01/2022 - 07/2003
4	Nausea 03/2022 - 05/2016
4	Obesity 11/2007 - 04/2005
3	Vomiting 01/2019 - 05/2016
3	Leukemia 11/2007 - 03/2005
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2007 - 04/2005
2	Osteosarcoma (Osteogenic Sarcoma) 01/2016 - 01/2014
2	Thrombocytopenia (Thrombopenia) 08/2006 - 07/2003
1	Toxic Optic Neuropathy 01/2022
1	Extranodal NK-T-Cell Lymphoma 03/2021
1	Aggressive Fibromatosis (Desmoid) 10/2020
1	Giant Cell Tumors (Giant Cell Tumor) 08/2015
1	Pancreatitis 03/2008
1	Neuroblastoma 03/2008
1	Rhabdomyosarcoma 03/2008
1	Ewing Sarcoma (Sarcoma, Ewing) 03/2008
1	Medulloblastoma 03/2008
1	Carcinoma (Carcinomatosis) 08/2006
1	Constipation 08/2006
1	Proteinuria 08/2006
1	Hyperkalemia 08/2006
1	Overweight 12/2005
1	Hyperglycemia 12/2005
1	Weight Gain 04/2005
1	Neutropenia 07/2003

Drug/Important Bio-Agent (IBA)

3	AntiemeticsIBA 01/2019 - 05/2016
2	becatecarin (XL 119)IBA 03/2008 - 07/2003
2	rebeccamycinIBA 03/2008 - 07/2003
1	cobimetinibIBA 01/2022
1	TabletsIBA 01/2022
1	SuspensionsIBA 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 03/2021
1	Immune Checkpoint InhibitorsIBA 03/2021
1	atezolizumabIBA 03/2021
1	Codon (Codons)IBA 10/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2019
1	salicylhydroxamic acid (SHAM)IBA 01/2018
1	EmeticsIBA 01/2018
1	Biological ProductsIBA 01/2016
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2016
1	Zoledronic Acid (Zometa)FDA Link 08/2015
1	MicroRNAs (MicroRNA)IBA 01/2014
1	Biomarkers (Surrogate Marker)IBA 01/2014
1	Lipase (Acid Lipase)FDA Link 03/2008
1	Amylases FDA Link 03/2008
1	CreatinineIBA 08/2006
1	irofulvenIBA 08/2006
1	Asparaginase (Elspar)FDA Link 12/2005
1	Insulin (Novolin)FDA Link 12/2005
1	Glucose (Dextrose)FDA LinkGeneric 12/2005
1	raltitrexed (D 1694)IBA 03/2005
1	AT 760IBA 07/2003

Therapy/Procedure

10	Drug Therapy (Chemotherapy) 03/2022 - 04/2005
7	Therapeutics 01/2021 - 07/2003
1	Acupressure (Shiatsu) 01/2018
1	Induction Chemotherapy 12/2005